Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion

International Journal of Hematology

Volumn 86, Issue 3, 2007, Pages 246-249

  Okazuka, Kiyoshi ^a,b   Masuko, Masayoshi ^a   Seki, Yoshinobu ^b   Hama, Hitomi ^b   Honma, Noriyuki ^b   Furukawa, Tatsuo ^a   Toba, Ken ^a   Kishi, Kenji ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b Shibata Prefectural Hospital   (Japan)

Author keywords

Acute promyelocytic leukemia; Chronic renal failure; Nucleophosmin retinoic acid receptor fusion

Indexed keywords

ANTINEOPLASTIC AGENT; NUCLEAR MITOTIC APPARATUS PROTEIN; NUCLEOPHOSMIN; PROMYELOCYTIC LEUKEMIA ZINC FINGER; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; STAT5B PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHILD; CHROMOSOME TRANSLOCATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE FUSION; GENE REARRANGEMENT; HEMODIALYSIS; HUMAN; LEUKEMIA REMISSION; MALE; MONOTHERAPY; NPM RAR GENE; NUMA GENE; PLZ F GENE; PROMYELOCYTIC LEUKEMIA; STAT5B GENE; TREATMENT RESPONSE; UREMIA;

ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; REMISSION INDUCTION; RENAL DIALYSIS; TRANSLOCATION, GENETIC; TRETINOIN; UREMIA;

EID: 36048998930     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03006928     Document Type: Article

References (15)

1. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood. 1996;87:882-886.
2. Chen Z, Brand NJ, Chen A, et al. Fusion between a novel Krüppel-like zinc linger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia. EMBO J. 1993;12:1161-1167.
3. Wells RA, Catzavelos C, Kamcl-Reid S. Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet. 1997;17:109-113.
4. Arnould C, Philippe C, Bourdon V, Gregoire MJ, Berger R, Jonveaux P. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor α in acute promyelocytic-like leukaemia. Hum Mol Genet. 1999;8:1741-1749.
5. Zelent A, Guidez F, Melnick A, Waxman S, Licht JD. Translocations of the RARα gene in acute promyelocytic leukemia. Oncogene. 2001;20:7186-7203.
6. Grimwade D, Lo Coco FL. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia. 2002;16:1959-1973.
7. Grimwade D, Biondi A, Mozziconacci MJ, et al, on behalf of the Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BlOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies." Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood. 2000;96:1297-1308.
8. Licht JD, Chomienne LC, Goy A, et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood. 1995;85:1083-1094.
9. Redner RL, Corey SJ, Rush EA, et al. Differentiation of t(5;17) variant acute promyelocytic leukemia blasts by all-trans retinoic acid. Leukemia. 1997;11:1014-1016.
10. Takitani K, Nagai K, Tamai H, et al. Pharmacokinetics of all-trans retinoic acid in acute promyelocytic leukemia patients on dialysis. Am J Hematol. 2003;74:147-148.
11. Hummel JL, Wells RA, Dubé ID, Licht JD, Kamel-Reid S. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia. Oncogene. 1999;18:633-641.
12. Xu L, Zhao WL, Xiong SM. Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia. Leukemia. 2003;15:1359-1368.
13. Betz JL, Behairy AS, Rabionet P, et al. Acquired inv(9): what is its significance? Cancer Genet Cytogenet. 2005;160:76-78.
14. Yamada K. Population studies of INV(9) chromosomes in 4,300 Japanese: incidence, sex difference and clinical significance. Jpn J Hum Genet. 1992;37:293-301.
15. Redner RL, Chen JD, Rush EA, Li H, Pollock SL. The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties. Blood. 2000;95:2683-2690.